Literature DB >> 20967529

[Sleeve gastrectomy in the treatment of morbid obesity. Study results and first experiences with the transvaginal hybrid NOTES technique].

M Buesing1, M Utech, J Halter, R Riege, G Saada, A Knapp.   

Abstract

BACKGROUND: Surgery for morbid obesity is also becoming more important in Germany. Besides standard procedures such as the Roux-en-Y (RNY) bypass, sleeve gastrectomy seems to be a new option which is mainly related to gastric restriction, neurohumoral changes and other unknown factors. The results of sleeve gastrectomy have to be compared with other established procedures such as the RNY bypass according the complication rate, weight loss and improvement of weight-related comorbidities such as diabetes and hypertension. PATIENTS AND METHODS: Between May 2008 and August 2009 sleeve gastrectomy was performed in a total of 200 patients (136 female and 64 male) with an obesity grade II-III. The average age of the patients was 43 years (range 21-72 years) and the average BMI 47.9 kg/m(2) (range 35.5-75.3 kg/m(2)). Of the patients 70 (35%) were diabetics and 96 (48%) suffered from hypertension. In 14 cases the operation was planned using the transvaginal assisted (hybrid NOTES) technique.
RESULTS: Laparoscopic sleeve gastrectomy was possible in all patients. Of the patients 3 (1.5%) suffered from postoperative complications, such as leakage from the suture line in 2 (1%) cases and in 1 case (0.5%) with hemorrhaging from the abdominal wall and subsequent pulmonary embolism resulting in a mortality rate of 1% (2 cases). In the 197 cases without complications the mean hospital stay was 3.5 days (range 2-9 days). Using the transvaginal technique the number of trocars could be reduced by 1-2 and in all cases the resected stomach was retrieved transvaginally. No complications occurred due to the vaginal access. Antidiabetic medication was stopped 3 months after the operation in 45 (64%) out of 70 diabetics and the need for antihypertension drugs was also reduced. The mean weight loss after 3, 6 and 12 months was 27.3%, 41% and 58%, respectively.
CONCLUSIONS: Sleeve gastrectomy seems to be an effective surgical option for the treatment of morbid obesity with a low complication rate. During the first year after the operation weight loss was excellent and weight-related comorbidities such as diabetes and hypertension improved significantly. The transvaginal hybrid NOTES technique can be performed but there is still need for additional trocars through the abdominal wall. Long-term results with respect to a durable weight loss and obesity-associated comorbidities are still lacking. The results of sleeve gastrectomy are at present comparable to those of a RNY bypass.

Entities:  

Mesh:

Year:  2011        PMID: 20967529     DOI: 10.1007/s00104-010-1990-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  23 in total

1.  Cancer in the excluded stomach 4 years after gastric bypass.

Authors:  Deborah A Corsini; Celso A M Simoneti; Gisele Moreira; Sizenando E Lima; Arthur B Garrido
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

2.  Single-laparoscopic incision transabdominal surgery sleeve gastrectomy.

Authors:  Kevin M Reavis; Marcelo W Hinojosa; Brian R Smith; Ninh T Nguyen
Journal:  Obes Surg       Date:  2008-08-10       Impact factor: 4.129

3.  Early experience with SILS port laparoscopic sleeve gastrectomy.

Authors:  Alan A Saber; Tarek H El-Ghazaly
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2009-12       Impact factor: 1.719

4.  Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results.

Authors:  Crystine M Lee; Paul T Cirangle; Gregg H Jossart
Journal:  Surg Endosc       Date:  2007-03-14       Impact factor: 4.584

5.  Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients.

Authors:  Philippe Mognol; Denis Chosidow; Jean-Pierre Marmuse
Journal:  Obes Surg       Date:  2005-08       Impact factor: 4.129

6.  Reinforcing the staple line during laparoscopic sleeve gastrectomy: prospective randomized clinical study comparing three different techniques.

Authors:  Giovanni Dapri; Guy Bernard Cadière; Jacques Himpens
Journal:  Obes Surg       Date:  2009-12-11       Impact factor: 4.129

Review 7.  Sleeve gastrectomy for morbid obesity.

Authors:  Andrew A Gumbs; Michel Gagner; Gregory Dakin; Alfons Pomp
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

8.  [Obesity - principles of surgical therapy].

Authors:  R A Weiner
Journal:  Chirurg       Date:  2008-09       Impact factor: 0.955

Review 9.  [Operative techniques and outcomes in metabolic surgery: sleeve gastrectomy].

Authors:  T P Hüttl; F W F Obeidat; K G Parhofer; N Zügel; P E Hüttl; K-W Jauch; R A Lang
Journal:  Zentralbl Chir       Date:  2009-02-25       Impact factor: 0.942

Review 10.  Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese.

Authors:  O N Tucker; S Szomstein; R J Rosenthal
Journal:  J Gastrointest Surg       Date:  2008-02-09       Impact factor: 3.452

View more
  6 in total

1.  Natural orifice translumenal endoscopic surgery applications in clinical practice.

Authors:  Ross S Coomber; Mikael H Sodergren; James Clark; Julian Teare; Guang-Zhong Yang; Ara Darzi
Journal:  World J Gastrointest Endosc       Date:  2012-03-16

2.  Systematic Review and Meta-analysis of Complications in Transvaginal Approach in Laparoscopic Surgery.

Authors:  Andrzej L Komorowski; Francisco Alba Mesa; Małgorzata M Bała; Jerzy W Mituś; Wojciech M Wysocki
Journal:  Indian J Surg       Date:  2014-02-05       Impact factor: 0.656

Review 3.  Excessive weight loss after sleeve gastrectomy: a systematic review.

Authors:  Lars Fischer; Caroline Hildebrandt; Thomas Bruckner; Hannes Kenngott; Georg R Linke; Tobias Gehrig; Markus W Büchler; Beat P Müller-Stich
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 4.  Changes in Antihypertensive Medication Following Bariatric Surgery.

Authors:  Gabriel S Tajeu; Emily Johnson; Mason Buccilla; Crystal A Gadegbeku; Shane Janick; Daniel Rubin; Rohit Soans; Vikram J Eddy; David B Sarwer
Journal:  Obes Surg       Date:  2022-01-26       Impact factor: 3.479

5.  Transvaginal natural orifice transluminal endoscopic surgery in the morbidly obese.

Authors:  Lucian Panait; Stephanie G Wood; Robert L Bell; Andrew J Duffy; Kurt E Roberts
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

6.  Transvaginal laparoscopic appendectomy simultaneously with vaginal hysterectomy: initial experience of 10 cases.

Authors:  Yu Tian; Shuo-Dong Wu; Ying-Han Chen; Dan-Bo Wang
Journal:  Med Sci Monit       Date:  2014-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.